<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04506762</url>
  </required_header>
  <id_info>
    <org_study_id>ESP ERCS</org_study_id>
    <nct_id>NCT04506762</nct_id>
  </id_info>
  <brief_title>Benefit of Peri-operative Bilateral ESP Catheters for Enhanced Recovery for Cardiac Surgery (ERCS)</brief_title>
  <acronym>ESP_ERCS</acronym>
  <official_title>Does Bilateral Continuous Peri Operative Erector Spinae Plane Block Improve The Enhanced Recovery Program After Open Heart Surgeries in Adults?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vinmec Healthcare System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vinmec Healthcare System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate if the addition of peri-operative regional analgesia by Bilateral ESP&#xD;
      catheters improves the enhanced recovery program after open heart surgeries for the duration&#xD;
      of hospitalisation, quality of analgesia, Consumption of peri-operative opioids, quality of&#xD;
      recovery and quality of life.&#xD;
&#xD;
      Patients will be randomly divided in 2 groups Group 1 With the actual standards of care for&#xD;
      enhanced recovery after cardiac surgery including opioid sparing peri operative analgesia&#xD;
      Group 2 With the actual standards of care for enhanced recovery after cardiac surgery&#xD;
      replacing the opioid analgesia by a peri operative analgesia by bilateral ESP catheters&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      I. CONSULTING PHASE: 1 WEEK BEFORE SURGERY&#xD;
&#xD;
        1. Preoperative information, education and counselling: patient and families receive&#xD;
           dedicated preoperative counselling including information packets.&#xD;
&#xD;
        2. Preoperative optimization: medical optimization before surgery, including renal,&#xD;
           pulmonary, and endocrine function.&#xD;
&#xD;
        3. Smoking and alcohol cessation: smoking and alcohol cessation advised and promoted before&#xD;
           surgery.&#xD;
&#xD;
        4. Preoperative nutrition status: patients screened for nutritional status and counselling&#xD;
           given for a protein-rich diet at least the week before the surgery.&#xD;
&#xD;
      II. PREOPERATIVE PHASE: 2 DAYS BEFORE SURGERY&#xD;
&#xD;
        1. Preoperative fasting and carbohydrate treatment: patients are kept NPO 8h before surgery&#xD;
           except for oral carbohydrate beverage given 2-4h before surgery.&#xD;
&#xD;
        2. Reviewed all examination results: cardiac echography, X-ray, biology's tests&#xD;
&#xD;
        3. Consents signed.&#xD;
&#xD;
        4. Authorization operative be signed&#xD;
&#xD;
        5. Preoperative multimodal analgesic initiated : before surgery 2 h Gabapentin: 600 mg&#xD;
           (P.O) Acetaminophen: 500 mg (P.O) Hydroxyzine: 50 mg (P.O)&#xD;
&#xD;
      III. INTRAOPERATIVE PHASE:&#xD;
&#xD;
        1. Monitoring: Usual Monitoring for Open heart surgery plus a pain monitor Ani&#xD;
&#xD;
           •&#xD;
&#xD;
        2. Anesthesia:&#xD;
&#xD;
           Drugs Ketamine Ketamin: 0,10 mg/kg (bolus) then 0.10 mcg/kg/h Propofol TCI mode Target&#xD;
           Entropy from 40-60 Sufentanil 1 mcg/kg (bolus for Intubation) then 0,1-1 mcg/kg/min (50&#xD;
           &lt; ANI , 70) Esmeron 0.6 - 1 mg/kg (bolus pour intubation) (TOF = 0) then 0.3 mg/kg/h 0.6&#xD;
           - 1 mg/kg (bolus pour intubation) (TOF = 0) then 0.3 mg/kg/h Esomeprazole 40 mg (IV)&#xD;
           Dexamethasone 0.1 mg/kg Magnesium 10 mg/kg then 10 mg/kg/h Antibio-prophylaxy Cefazolin&#xD;
           2g (IV) or vancomycin 15 mg/kg before incision 1 hours.&#xD;
&#xD;
           erector spinae plane (ESP) block insertion cathter 30 - 40 kg = 6 mL / side 40 - 50 kg =&#xD;
           8 mL / side 50 - 60 kg = 10 mL / side 60 - 70 kg = 12 mL / side &gt; 70 kg = 14 mL / side&#xD;
&#xD;
           Tramexamic Acid 2 g ( IV) 2 g (IV) Heparin 3mg/kg (bolus in Central line), 25 mg in By&#xD;
           Pass 3mg/kg (bolus in Central line), 25 mg in By Pass&#xD;
&#xD;
           ESP catheter Performance (Kit epidural for adult Tuohy needle 19 G Catheter 20G) It is&#xD;
           strictly forbidden to withdraw the inserted catheter throw the needle. If you need to&#xD;
           retrieve the catheter you must retrieve the needle with the catheter.&#xD;
&#xD;
           Patient in Right Lateral decubitus only if Hemodynamic stable US control of needle tip&#xD;
           (dextrose 5%) Insertion of Catheter 20G under US visualization Tip to the top of the&#xD;
           next transverse process Test the catheter with dextrose and see the spread of the liquid&#xD;
           under US guidance in the interfascial space anterior to the ES muscle.&#xD;
&#xD;
             -  Induction 30 min before incision&#xD;
&#xD;
             -  Identify the 2 catheters by Yellow labels (Regional analgesia code)&#xD;
&#xD;
             -  No Variation of BP during sternotomy = ESP efficient If not Sufentanil Bolus&#xD;
&#xD;
           Coagulation test before to start By Pass ACT &gt; 400 secondes BEFORE start by pass .&#xD;
           Inform Surgeon (Do NOT START If NOT)&#xD;
&#xD;
        3. Cardiac by pass:&#xD;
&#xD;
           • Cannulation Time Aortic Y cave Venous Sup and Inf or AtrioCave Connection to By Pass&#xD;
           Air Lock Start By Pass = Volume 950-1000 ml (Ringer lactate, Gelofusine, Mannitol &amp;t&#xD;
           Natri bicarbonate.); Aortic clamp; Cardioplegia Type Cold: crystalloid 4-8 degree&#xD;
           celsius (CUSTODIOL);&#xD;
&#xD;
           Anaesthesia Action:&#xD;
&#xD;
           Stop Ventilation disconnect ETtube/ VA Circuit only when Bypass provide a full&#xD;
           hemodynamic CO= 2.4.BSA l/m2.min. in and out (message FULL FLOW from perfusionist)&#xD;
&#xD;
           Maintenance anesthesia depth by ENTROPY 40-60, ANI &gt;40 Perfusionist targets MAP 50-80&#xD;
           mmHg , CO = 2, 4. BSA (L/m2.min.) SVO2 &gt; 75% Blood tests /30 mn (ABG , lactate, Hb,&#xD;
           Glycemie, ACT with heparin reinjection )&#xD;
&#xD;
        4. Before Getting Out Of By Pass:&#xD;
&#xD;
             -  Anaesthesia Actions Ventilation&#xD;
&#xD;
             -  Restart Ventilation + Reconnect ETtube-&gt; VA Circuit&#xD;
&#xD;
             -  Recruitment Manoeuvers low pressure Temperature and warming Cross clamp time Rhythm&#xD;
                Monitoring Turn on the alarms De-Airing manoeuvres by surgeon &amp; by anesthesiologist&#xD;
                with Control by TEE. Evaluation the result of surgeon and EF before decision to use&#xD;
                inotropes or not.&#xD;
&#xD;
             -  Removal Aortic Clamp and spontaneous defibrillation&#xD;
&#xD;
             -  Perfusion and vaso active drugs assistance SVR - MAP- CVP -CI-SVRI-SVV&#xD;
&#xD;
             -  Inotropes - Vasoconstrictors - Volemia&#xD;
&#xD;
             -  Removal Veinous Canule&#xD;
&#xD;
        5. After Bypass:&#xD;
&#xD;
             -  Test de pace-maker&#xD;
&#xD;
             -  Protamin: Slow IV protamine (dose protamine = dose heparin Total given)&#xD;
&#xD;
             -  Transamin : 2g (IV)&#xD;
&#xD;
             -  Ondansetron 4 mg (IV) - PONV prophylaxy&#xD;
&#xD;
             -  Blood tests 15 min after protamin: ABG Lactate, APTT, PT, FIBRINOGEN, Hb, Glycemia,&#xD;
                NFS,&#xD;
&#xD;
             -  ACT to base line : 120-130 if not =&gt; More protamine&#xD;
&#xD;
             -  Blood transfusion if Hb &lt; 10g/dL or Hct &lt; 30%&#xD;
&#xD;
             -  Platelet transfusion if PLT&lt; 80 000&#xD;
&#xD;
             -  Plasma fresh frozen transfusion if TP &lt; 50%&#xD;
&#xD;
             -  Drains check.&#xD;
&#xD;
             -  Check coagulation total and blood gaz test&#xD;
&#xD;
             -  Ventilation recruitments manoeuvres&#xD;
&#xD;
      IV. POSTOPERATIVE PHASE:&#xD;
&#xD;
        1. CICU transfer:&#xD;
&#xD;
           According to guidelines intubated ventilated patient transfer.&#xD;
&#xD;
        2. CICU:&#xD;
&#xD;
           • Information according to guidelines Reception patient from OT&#xD;
&#xD;
           • Identification of the 2 regional analgesia ESP catheters (Yellow Labels)&#xD;
&#xD;
           • Drains check&#xD;
&#xD;
           • Blood test on arrival ABG , Lactate, Hb, Glycemia, NFS, RP, ECG at arrival CICU&#xD;
&#xD;
           • ABG, glycemie repeat every 4 hours&#xD;
&#xD;
           • Sedation : Stable patient propofol 30-50 mg/h for 2 hours and stop when weaning&#xD;
           criteria riched&#xD;
&#xD;
           • Protocol for analgesia:&#xD;
&#xD;
           all groups&#xD;
&#xD;
           Paracetamol 1g/6h (infusion) Ketorolac 30 mg/8h Nefopam 100 mg/24h&#xD;
&#xD;
           ESP Catheter with analgesia solution Micrel Pumps with intermittent automatic bolus&#xD;
           (IAB) connected and started at T0&#xD;
&#xD;
           Pump preparation and settings:&#xD;
&#xD;
           -Patient 30 - 40 kg = 6 mL / side/6h&#xD;
&#xD;
           -Patient 40 - 50 kg = 8 mL / side/6h&#xD;
&#xD;
             -  Patient 50 - 60 kg = 10 mL/ side/6h&#xD;
&#xD;
             -  Patient 60 - 70 kg = 12 mL/ side/6h&#xD;
&#xD;
             -  Patient &gt; 70 kg = 14 mL / side/6h The bolus on the second catheter will be delayed&#xD;
                by 1 hour Intermittent programmed bolus every 6h&#xD;
&#xD;
           Rescue analgesia Morphine 50 mcg/kg/min if FLACC &gt;3 or ANI &lt; 40&#xD;
&#xD;
           • Fluid management: goal directed fluid therapy (GDFT) controlled by hemodynamics&#xD;
           monitoring (Flotrac): CI, SVV, SVRI, CVP.&#xD;
&#xD;
           Glucose 5%: 01 ml/kg/h + electrolyte balance. Bilan import, export/ 6hours • Early&#xD;
           extubation: (criteria weaning and extubation appendix 1)&#xD;
&#xD;
           • Early mobilization: After extubation 4 hours, sitting in bed and moving thoracic.&#xD;
&#xD;
           Analgeia protocle after extubation If Continuous infusion of morphine replace by&#xD;
           Morphine PCA • Concentration Morphine : 50 mg/49 ml + Ketamine 50 mg • Loading dose: 1mg&#xD;
&#xD;
           • PCA dose demand: 1 mg/dose&#xD;
&#xD;
           • Lockout: 10 min&#xD;
&#xD;
           • Continuous rate (basal): 0&#xD;
&#xD;
             -  Dose limit (hr): 6mg/hour&#xD;
&#xD;
           Plan with daily goals for time out of bed and distance walked beginning as soon as the&#xD;
           day of surgery.&#xD;
&#xD;
           • Early feeding: No sonde gastric Prevention PONV Drinking clear liquids after&#xD;
           extubation 4 hours, eating after 6 hours.&#xD;
&#xD;
      4. Criteria drain thoracic removal:&#xD;
&#xD;
        -  Liquid of mediastenal drains = 0 ml/ 2h;&#xD;
&#xD;
        -  No pleural effusion major;&#xD;
&#xD;
        -  No pneumothorax major;&#xD;
&#xD;
        -  ESP catheters removed 4h after drain removal;&#xD;
&#xD;
        -  After ESP catheter removed analgesia in both group only by:&#xD;
&#xD;
      Efferalgan : 15-20 mg/kg/6h (P.O) Ibuprofen : 400 mg/8h (P.O) Gabapentin : 300 mg/6h (P.O) (5&#xD;
      days postop) 5. Discharge from CICU( criteria discharge appendix 1):&#xD;
&#xD;
      • VAS scores at rest and mob during hospitalization&#xD;
&#xD;
        -  VAS scores at rest and mob at 1 month with return to normal activities&#xD;
&#xD;
           6. Pain Evaluation:&#xD;
&#xD;
        -  Patient Intubated scale FLACC , at rest and after pressure on sternum &amp; drain&#xD;
           mobilization every 6 hours&#xD;
&#xD;
        -  Post extubation still drains VAS scale rest and Mob (sitting in bed moving thorax) ASAP&#xD;
           after extubation and every 6h&#xD;
&#xD;
        -  Localization of the pain VAS Sternum Back pain Drains&#xD;
&#xD;
        -  After drains removed VAS rest and Mob ( sitting in bed moving thorax) and pain&#xD;
           localization Pain (VAS rest ) just after Mediastinal drain removal if possible; Pain&#xD;
           (VAS rest and mob every 8 h) in the ward; Pain at one month (VAS rest and mob).&#xD;
&#xD;
           7. Discharge from hospital: (criteria discharge appendix 1)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Prospective Controled</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of post operative stay in Hospital</measure>
    <time_frame>10 days</time_frame>
    <description>Duration of hospitalisation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of post operative stay in Intensive care unit</measure>
    <time_frame>3 days</time_frame>
    <description>Duration of stay in Intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to 1st mobilisation</measure>
    <time_frame>3 days</time_frame>
    <description>1st Time to stand up out of bed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>1 month</time_frame>
    <description>Quality of recovery using the scale QOR 16</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Open Heart Surgery</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care for peri operative analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral ESP catheters for peri operative regional analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Regional analgesia</intervention_name>
    <description>Insertion of bilateral ESP catheters</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Open heart surgeries: Valvulopathies ( 1-2 valves, repair or replacement)&#xD;
&#xD;
          -  Congenital heart disease (Risk Adjustment in Congenital Heart Surgery Category 1-2 (&#xD;
             VSD, ASD, T4F)&#xD;
&#xD;
          -  NYHA II,&#xD;
&#xD;
          -  Fraction ejection &gt; 50%,&#xD;
&#xD;
          -  PAPS &lt; 50 mmHg.&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Age from 18-60 years old.&#xD;
&#xD;
          -  Consent participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal participation.&#xD;
&#xD;
          -  Allergy to LA&#xD;
&#xD;
          -  Severe thoracic Scoliosis&#xD;
&#xD;
          -  Valvulopathies association with :&#xD;
&#xD;
          -  CABG&#xD;
&#xD;
          -  BENTALL procedure&#xD;
&#xD;
          -  Deficit mental&#xD;
&#xD;
          -  Alcoholics,&#xD;
&#xD;
          -  Heroine addicted&#xD;
&#xD;
          -  Insufficient renal&#xD;
&#xD;
          -  liver failure&#xD;
&#xD;
          -  Endocarditis &lt;1 year&#xD;
&#xD;
          -  Stroke &lt;3 months&#xD;
&#xD;
          -  MI &lt;3 months&#xD;
&#xD;
          -  Bloc AV II or III with Pacemaker permanent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Macaire, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vinmec Healthcare System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chi Nguyen, MSC</last_name>
    <phone>+84834182013</phone>
    <email>nguyen.yen.chi123@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Noss C, Prusinkiewicz C, Nelson G, Patel PA, Augoustides JG, Gregory AJ. Enhanced Recovery for Cardiac Surgery. J Cardiothorac Vasc Anesth. 2018 Dec;32(6):2760-2770. doi: 10.1053/j.jvca.2018.01.045. Epub 2018 Jan 31. Review.</citation>
    <PMID>29503121</PMID>
  </reference>
  <reference>
    <citation>Brown JK, Singh K, Dumitru R, Chan E, Kim MP. The Benefits of Enhanced Recovery After Surgery Programs and Their Application in Cardiothoracic Surgery. Methodist Debakey Cardiovasc J. 2018 Apr-Jun;14(2):77-88. doi: 10.14797/mdcj-14-2-77. Review.</citation>
    <PMID>29977464</PMID>
  </reference>
  <reference>
    <citation>Williams JB, McConnell G, Allender JE, Woltz P, Kane K, Smith PK, Engelman DT, Bradford WT. One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program. J Thorac Cardiovasc Surg. 2019 May;157(5):1881-1888. doi: 10.1016/j.jtcvs.2018.10.164. Epub 2018 Dec 8.</citation>
    <PMID>30665758</PMID>
  </reference>
  <reference>
    <citation>Macaire P, Ho N, Nguyen T, Nguyen B, Vu V, Quach C, Roques V, Capdevila X. Ultrasound-Guided Continuous Thoracic Erector Spinae Plane Block Within an Enhanced Recovery Program Is Associated with Decreased Opioid Consumption and Improved Patient Postoperative Rehabilitation After Open Cardiac Surgery-A Patient-Matched, Controlled Before-and-After Study. J Cardiothorac Vasc Anesth. 2019 Jun;33(6):1659-1667. doi: 10.1053/j.jvca.2018.11.021. Epub 2018 Nov 19.</citation>
    <PMID>30665850</PMID>
  </reference>
  <reference>
    <citation>Milgrom LB, Brooks JA, Qi R, Bunnell K, Wuestfeld S, Beckman D. Pain levels experienced with activities after cardiac surgery. Am J Crit Care. 2004 Mar;13(2):116-25.</citation>
    <PMID>15043239</PMID>
  </reference>
  <reference>
    <citation>Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology. 2006 Oct;105(4):794-800.</citation>
    <PMID>17006079</PMID>
  </reference>
  <reference>
    <citation>Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017 Jul 1;152(7):691-697. doi: 10.1001/jamasurg.2017.0898. Review.</citation>
    <PMID>28564673</PMID>
  </reference>
  <reference>
    <citation>Bigeleisen PE, Goehner N. Novel approaches in pain management in cardiac surgery. Curr Opin Anaesthesiol. 2015 Feb;28(1):89-94. doi: 10.1097/ACO.0000000000000147. Review.</citation>
    <PMID>25500688</PMID>
  </reference>
  <reference>
    <citation>Bignami E, Castella A, Allegri M. Postoperative Pain After Cardiac Surgery: An Open Issue. J Cardiothorac Vasc Anesth. 2018 Feb;32(1):e24-e25. doi: 10.1053/j.jvca.2017.09.022. Epub 2017 Sep 20.</citation>
    <PMID>29217242</PMID>
  </reference>
  <reference>
    <citation>Carli F, Kehlet H, Baldini G, Steel A, McRae K, Slinger P, Hemmerling T, Salinas F, Neal JM. Evidence basis for regional anesthesia in multidisciplinary fast-track surgical care pathways. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):63-72. doi: 10.1097/AAP.0b013e31820307f7. Review.</citation>
    <PMID>22002193</PMID>
  </reference>
  <reference>
    <citation>Wong WT, Lai VK, Chee YE, Lee A. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2016 Sep 12;9:CD003587. doi: 10.1002/14651858.CD003587.pub3. Review.</citation>
    <PMID>27616189</PMID>
  </reference>
  <reference>
    <citation>Zhu F, Lee A, Chee YE. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2012 Oct 17;10:CD003587. doi: 10.1002/14651858.CD003587.pub2. Review.</citation>
    <PMID>23076899</PMID>
  </reference>
  <reference>
    <citation>Krishna SN, Chauhan S, Bhoi D, Kaushal B, Hasija S, Sangdup T, Bisoi AK. Bilateral Erector Spinae Plane Block for Acute Post-Surgical Pain in Adult Cardiac Surgical Patients: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2019 Feb;33(2):368-375. doi: 10.1053/j.jvca.2018.05.050. Epub 2018 Jun 4.</citation>
    <PMID>30055991</PMID>
  </reference>
  <reference>
    <citation>Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292-298. doi: 10.1001/jamasurg.2016.4952. Review.</citation>
    <PMID>28097305</PMID>
  </reference>
  <reference>
    <citation>Nicholson A, Lowe MC, Parker J, Lewis SR, Alderson P, Smith AF. Systematic review and meta-analysis of enhanced recovery programmes in surgical patients. Br J Surg. 2014 Feb;101(3):172-88. doi: 10.1002/bjs.9394. Review.</citation>
    <PMID>24469618</PMID>
  </reference>
  <reference>
    <citation>Engelman RM, Rousou JA, Flack JE 3rd, Deaton DW, Humphrey CB, Ellison LH, Allmendinger PD, Owen SG, Pekow PS. Fast-track recovery of the coronary bypass patient. Ann Thorac Surg. 1994 Dec;58(6):1742-6.</citation>
    <PMID>7979747</PMID>
  </reference>
  <reference>
    <citation>Myles PS, Daly DJ, Djaiani G, Lee A, Cheng DC. A systematic review of the safety and effectiveness of fast-track cardiac anesthesia. Anesthesiology. 2003 Oct;99(4):982-7. Review.</citation>
    <PMID>14508335</PMID>
  </reference>
  <reference>
    <citation>Sola M, Ramm CJ, Kolarczyk LM, Teeter EG, Yeung M, Caranasos TG, Vavalle JP. Application of a Multidisciplinary Enhanced Recovery After Surgery Pathway to Improve Patient Outcomes After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2016 Aug 1;118(3):418-23. doi: 10.1016/j.amjcard.2016.05.015. Epub 2016 May 14.</citation>
    <PMID>27344271</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 4, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vinmec Healthcare System</investigator_affiliation>
    <investigator_full_name>Philippe Macaire</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Erector spinae Catheter</keyword>
  <keyword>Enhanced Recovery after Cardiac Surgery</keyword>
  <keyword>Peri operative regional analgesia for open heart surgery</keyword>
  <keyword>Quality of recovery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

